Tuesday 31 July 2012

Food and Drug Administration Approves Senesco’s SNS01-Torphan-Drug


Senesco Technologies, Inc. confirmed that it appeared to be informed on July 26th that the U.S. Food and Drug Administration (FDA) has approved orphan-drug designation regarding the company's lead drug candidate SNS01-T for remedy for both mantle cell lymphoma (MCL) and diffuse large B-cell lymphoma (DLBCL). Consequently, the firm is eligible to obtain a number of advantages, such as tax credits, admittance to grant funding for clinical trials, faster FDA approval, allowance for marketing exclusivity after drug sanction obtain a period of so long as seven years and potential exemption direct from FDA's prescription drug application cost.

"We are actually pleased mantle cell and diffuse large B-cell lymphomas join in with multiple myeloma upon the list of cancers for which SNS01-T is granted orphan-drug condition through FDA," said Leslie J. Browne, Ph.D., Senesco's Chief Executive Officer.

"SNS01-T was created to selectively trigger cell dying in B-cell malignancies. Finding orphan-drug status all these cancers are complemented from the efficacy of SNS01-T in mouse models of MCL and DLBCL in addition to our plans to consider the overall impact of SNS01-T in affected individuals with these cancers."
The United States Orphan Drug Act of 1983 was made to present the introduction of brand new drug therapies concerning the remedy for diseases that affect less than 200,000 individuals in the US.

Tuesday 24 July 2012

Once in a Day Gralise Reduces Pain in PHN Patients


Depomed, Inc. (NASDAQ: DEPO) today introduced that a report of Phase 3 data posted on the net this month, ahead of the print edition, within the Clinical Journal of Pain confirmed that once-daily Gralise (gabapentin) tablets (1,800 mg) formulation substantially lowers magnitude of discomfort in affected individuals along with postherpetic neuralgia (PHN). The results confirmed that affected individuals treated along with Gralise experienced a major decline in their average daily pain magnitude in comparison to placebo handled affected individuals.

The published achievements came from a randomized, multi-center Phase III clinical study of 452 affected individuals with PHN that tested the efficacy and overall safety of once-daily Gralise in comparison with placebo. Other results showed that this frequency of adverse events frequently related to gabapentin was as shown below: dizziness is 11.3% vs. placebo, 1.7%, somnolence is 5.4% vs. placebo 3.0%, and peripheral edema is 3.2% vs. placebo, 0.4% with differences in dizziness and peripheral edema being statistically large. Secondary endpoints confirmed that 43% of affected individuals taken care of with Gralise reported "much" or "very much" development in comparison with 34% of placebo treated affected individuals.

"Our research has shown that affected individuals treated along with Gralise experienced large alleviation of their daily pain stress level," said Christine N. Sang, MD, MPH, director of Translational Pain Research, Brigham and Women's Hospital, Harvard Medical School. "This discovery is encouraging due to the reason that the pain linked to PHN has a significant influence on patients' daily lives and such results recommend that Gralise, in part due to its gastroretentive formulation, could fill a necessary therapy gap for affected individuals with PHN."

Once-daily Gralise (1800 mg) was well put up within the survey, by having lower incidence of common adverse effects (AEs) than previously confirmed in other gabapentin studies. Within the Phase III study, 210 affected individuals reported AEs, 118 within the Gralise treated population, and 92 in the placebo handled group. The commonest AEs reported came with dizziness, headache and nausea. Ten serious AEs were really reported, four within the Gralise treated group of individuals, and six within the placebo treated group. Not a single one of the SAEs were attributable to the research drug.

Raisins and Sport Chews are Equal Providing Workout Boost


Research published in the Journal of the International Society of Sports Nutrition recommends that eating raisins may supply the same workout improvement as sports chews.

Conducted by experts at the University of California-Davis, the study evaluated the effects that natural versus commercial carbohydrate supplements have on endurance running performance. Runners depleted their own glycogen stores in an 80-minute 75% V02 max run leading to a 5k time trial. Runners finished about three randomized trials separated by a week. Findings came with:

Those that ingested raisins or sports chews ran their own 5k typically one minute a lot faster than those that ingested only water.

Eating raisins and sports chews elevated higher carbohydrate oxidation in comparison with water only.

"Raisins are a stunning substitute for sport chews as they offer fiber and micronutrients, an example would be potassium and iron, and these do not have any added sugar, artificial flavor or colors," said James Painter, Ph.D., R.D., and nutrients research advisor for the California Raisin Marketing Board. "As a possible added bonus, raisins will be the most inexpensive dried fruit in accordance with the United Stated Department of Agriculture, so that they are affordable and well-situated to utilize during workout."

Ocular Therapeutix Declares Results on Glaucoma


Ocular Therapeutix, Inc. introduced preliminary results of their sustained release travoprost-loaded punctum plug feasibility survey regarding the remedy for glaucoma. This travoprost punctum plug (OTX-TP1) seemed to be evaluated for the reduction of heightened intraocular strain in subjects along with open-angle glaucoma or ocular hypertension over a thirty-day period.

Twenty six eyes were really treated in 17 affected individuals at the Singapore National Eye Center and of course the National University Hospital in Singapore. Just before the insertion of the plugs, mean intraocular pressure at baseline for the study group appeared to be recorded at 26.3 mm Hg. Intraocular pressure (IOP) dropped by 5.5 mm Hg at day-3 post-insertion, and after one month of treatment, mean IOP appeared to be 6.5 mm Hg below baseline. The OTX-TP1 is designed to absorb in about 4 to 6 weeks, and 88% of plug were really present at the day-30 visit. Plugs last in the nasolacrimal canal on day 30 were discharged. One affected person demonstrated extreme tearing. Apart from that, there were no visual complaints outside normal confines, and affected individuals were cozy overall.

Results are similar to topical trusted brand name ophthalmic solutions, Travatan, Lumigan, and Xalatan. However, topical groups are plagued along with problems with non-compliance, which can lead to expensive and invasive surgeries, vision impairment, in addition to blindness. It really has been reported that up to 60% of affected individuals tend not to administer ophthalmic drops as organized, although patients' perception is the fact that they are compliants along with 97% of their total dosing. Sustained release travoprost punctum plugs could help to circumvent these problems of affected person non-compliance by eliminating the demand for daily dosing.

"This product has the ability to universally alter the way our team treats glaucoma," stated Shamira Perera, M.D., Principal Investigator at the Singapore National Eye Center. "Sustained release therapy could probably a top-rated to elderly affected individuals who have problems with administering drops, could possibly help alleviate problems with non-compliance, and may possibly be favourable to anyone clinically determined with glaucoma who may prefer a lifestyle without having the inconvenience of taking drops daily."

Tuesday 17 July 2012

Cubist Pharmaceuticals Announced CB-315 Phase 3 Trial of Diarrhea


Cubist Pharmaceuticals, Inc. introduced the initiation of the pivotal Phase 3 studies understanding the efficacy and overall safety of CB-315 in affected individuals along with Clostridium difficile-associated diarrhea, or CDAD, along with enrollment of an affected person to begin with of two plotted out identical global tests. These are generally randomized, double-blind, global studies wherein CB-315 (250 mg BID) is being compared with the active comparator oral vancomycin (125 mg QID). Each trial is predicted to actually enroll 608 eligible affected individuals.

Each of these studies are created to evaluate the distinction in clinical response rates for the end-of-therapy (EOT) in patients handled along with CB-315 versus oral vancomycin, in addition to safety of CB-315 in subjects with CDAD. Additionally, these research studies will evaluate maintained clinical result after therapy.

Cubist's Chief Scientific Officer Steve Gilman, PhD, said: "The rates and intensity of CDAD are increasing due partly to the spread of a new strain of C. difficile with higher virulence. We happen to be incredibly pretty excited to have the ability to improve CB-315 as a possible therapy, and current announcement fingerprints an important goal as we always build a portfolio of possible new therapies for severely sick affected individuals."

James J. Peters Veterans Hospital Recruits Individuals for NIC5-15 phase IIb trial in AD


The James J. Peters Veterans Hospital in Bronx, New York, is definitely recruiting individuals obtain a phase IIb clinical trial checking NIC5-15, a sickness modifying nominee for Alzheimer's disease.

Humanetics Corporation has created the utilization of NIC5-15 in collaboration along with Mount Sinai School of Medicine's Alzheimer's Disease Research Center (ADRC), an extensive clinical program and study facility. The US Patent and Trademark Office issued a patent for use of NIC5-15 in June. Humanetics has solely qualified the patent by means of MSSM's Office of Technology and Business Development.

NIC5-15 is shown in preclinical research studies and animal models to remain effective in stopping the formulation of beta-amyloid plaques, which is thought to be a leading reason behind Alzheimer's disease. Multiple medical studies in non-Alzheimer's people have demonstrated the security and phamacokinetics of NIC5-15.

Negative Effect on Foetal Growth for Standing in pregnancy


Standing for extended periods while pregnant may curb the expansion of the establishing foetus, implies research published on the net in Occupational and Environmental Medicine.

Preceding study has indicated that long functioning hours may raise the risk of birth defects, early birth, and stillbirth and reduced birth weight.

The scientists assessed the foetal growth occurrences of 4,680 mums-to-be from early pregnancies and so on between 2002 and 2006.

Halfway through their own pregnancy, the ladies were really quizzed about their work stipulations and of course the physical demands of their total jobs, which includes whether these included lifting, sustained periods of standing or walking, night shifts and prolonged working hours.

Women who exactly spent sustained periods on their feet in the course of their pregnancy, in jobs an example would be sales, childcare, and educating, had babies those heads were really an average of 1cm (3 %) less than average at birth, implying a reduced growth rate.

Around half the ladies (47.5 per cent) worked between 25 and 39 hours every week, despite the fact that around one in four (23 %) worked a little over 40 hours every week. And those that worked more often 40 hours every week had smaller babies compared to those who worked under 25 hours every week.

Babies born to these women had a head outline which was a 1cm smaller as well as a weight that was between 148g and 198g smaller, typically, than infants born to women carrying out work less than 25 hours every week.

Sexting Leads to Risky Sexual Behaviors in Teenagers


Research of US students at seven public high schools in Texas advice that a sexting was widely found and may be connected to teens sexual behaviors, based on a report posted in net first from the Archives of Pediatrics & Adolescent Medicine.

“Sexting” a blend of the words sex and texting will be the practice of digitally sending sexually explicit images or messages from a place person for some other.

Dr Jeff R Temple related to University of Texas Medical Branch Health, Galveston, and professionals being used data from part of a longitudinal survey and 948 candidates (55.9 % female).
Youngsters, who ranged in age from 14 to 19 years old, self-reported their roots or history of relationship, sexual behaviors and sexting.

Researchers evaluated teenager sexting with four queries: had they ever delivered naked pictures of their own selves through textual content or email; had they ever requested someone to get them a naked picture; had they actually been asked to mail naked pictures of their own selves to actually someone; and, in that case, how bothered were really they by it.

Specifically, more than one in four teenagers have sent a nude photo of themselves via electronic means, about 50 % have been requested to send a naked picture, and about a third have requested a naked picture as being sent to them. Boys were more likely to ask and girls at increased risk for being requested a sext, the authors noted.

The research also suggested that for both girls and boys, teens who exactly sexted were at increased risk for begun dating and also to have had sex compared to those who didn't sext.

Asian-American victims Infrequently Seek Help from Police

Asian-American victims of domestic violence infrequently look for help from police or medical professionals - "an alarming trend" among the many fastest-growing racial groups in the United States, says a Michigan State University researcher.

While ethnic barriers can suppress victims from finding help, there also is not enough culturally touchy services offered to them, said Hyunkag Cho, assistant professor of cultural work.

"Resources and health care providers should be there with maximum information and resources for adequately dealing with the requirements of victims of domestic violence among Asians along with other racial minorities," Cho said.

Based on a recent Pew Research Center state, Asian-Americans are now the quickest growing racial group in the United States, making up 36 percent of most immigrants who found its way to 2010. Latinos were really second, at 31 percent.

Friday 6 July 2012

Autism Spectrum Disorder by Mental Illness


Schizophrenia or bipolar disorder in first-degree family, an example would be parents or siblings, can be linked to increase danger of autism spectrum disorder (ASD).

Based on a new Swedish-Israeli report posted online first from the Archives of General Psychiatry, the existence of schizophrenia in mothers and fathers was linked to a higher risk for ASD in a Swedish nationwide collection of people sample (odds ratio (OR), 2.9) and a Stockholm County, Sweden, group (OR, 2.9), survey consequences confirmed.

Using human population registers in Sweden and Israel, Dr. Patrick F Sullivan of the University of North Carolina and colleagues discovered that schizophrenia within the sibling also ended up being linked to a higher risk for ASD in the Swedish national group (OR, 2.6) and the Israeli conscription people (OR, 12.1).

Bipolar disorder showed an equivalent pattern of connection, but of a lesser degree, the outcomes indicated. “Our findings imply that ASD, schizophrenia and bipolar problems impart aetiologic risk factors. We propose that future study could usefully effort to discern factors common to each of these disorders,” the authors stated.

Heart Problems Increases with Atkins-Style Diets


Women who might daily have a low-carbohydrate, high-protein diet plan are at greater danger of cardiovascular disease (CVD) than those that never, research posted on bmj.com implies.

While the actual quantities are small, the clinicians said that this is a 28 % increase in the volume of cases understanding that these achievements are worrying within the population of younger ladies who can be exposed to these diet preferences and face the excess risk for a long time.

A group of international doctors achieved research on slightly below 44,000 Swedish ladies older between 30 and 49 years from 1991-92 (with an average follow-up of 15 years).

Women finished an in-depth diet and lifestyle survey and diet ended up being measured by the low carbohydrate-high protein (LCHP) score, whereby a score of 2 would identical very high carbohydrates and low protein absorption, through to 20, which might identical incredibly low carbohydrate and very high protein ingestion.

After variables were really included, achievements confirmed that 1,270 cardiovascular activities happened within the 43,396 ladies (55 % ischemic heart problem, 23 % ischemic stroke, 6 % hemorrhagic stroke, 10 % subarachnoid hemorrhage and 6 % peripheral arterial disorder) over 15 years. The frequency of cardiovascular consequences elevated with an improving LCHP score.